Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Cholangiocarcinoma × Matrix Metalloproteinases × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Cholangiocarcinoma 1

Interventions

lenvatinib 3 Surgical Procedures, Operative 3 Cholangiopancreatography, Endoscopic Retrograde 3 Blood Specimen Collection 3 Oxaliplatin 2 Liquid Biopsy 2 Immunohistochemistry 2 Immune Checkpoint Inhibitors 2 Hepatectomy 2 Base Sequence 2 pembrolizumab 1 gemcitabine-oxaliplatin regimen 1 envafolimab 1 Vascular Endothelial Growth Factor A 1 Urination 1 Tegafur 1 S 1 (combination) 1 Radiotherapy 1 Polymerase Chain Reaction 1 Pancreaticoduodenectomy 1 Palliative Care 1 Observation 1 Neoadjuvant Therapy 1 Microbiota 1 Methylation 1 Matrix Metalloproteinases 1 Mass Spectrometry 1 Liver Transplantation 1 Leucovorin 1 Interviews as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02893085 2016-12-28

ONCOBIL

CHU de Reims

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡